Annovis Bio, Inc. Quarterly Nonoperating Income (Expense) in USD from Q1 2019 to Q3 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Annovis Bio, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2019 to Q3 2024.
- Annovis Bio, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$8.25M, a 5726% decline year-over-year.
- Annovis Bio, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$10.5M, a 1659% decline year-over-year.
- Annovis Bio, Inc. annual Nonoperating Income (Expense) for 2023 was -$11.2M, a 6213% decline from 2022.
- Annovis Bio, Inc. annual Nonoperating Income (Expense) for 2022 was $183K, a 265% increase from 2021.
- Annovis Bio, Inc. annual Nonoperating Income (Expense) for 2021 was $50.1K, a 95.7% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)